Lancet March 2026 Epidemiology, ventilation, and outcomes of acute respiratory failure in immunocompromised patients from 103 intensive care units in 26 countries: a retrospective observational study

This international study investigates the clinical landscape for immunocompromised individuals suffering from acute respiratory failure, a primary driver of intensive care admissions. By analyzing nearly ten thousand patients across twenty-six countries, researchers identified that infectionand malignancies are the most common underlying triggers, resulting in a high thirty-day mortality rate of over 47%. The findings highlight critical prognostic factors, such as age, frailty, and the specific cause of lung distress, while noting that certain treatments like high-flow nasal oxygenmay offer protective benefits. Ultimately, this research provides a vital framework for clinicians to make informed management decisions and improve survival outcomes for this highly vulnerable population.